In our experiments, the higher expression of MAP3K2 in patients with colon cancer was negatively correlated with the miR-372-3p expression, indicating that MAP3K2 may be a potential target of miR-372-3p. This evidence concerns the gene MAP3K2 and malignant colon neoplasm.